Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Educational video intervention improves knowledge and self-efficacy in identifying malnutrition among healthcare providers in a cancer center: a pilot study.

Wolf PG, Manero J, Harold KB, Chojnacki M, Kaczmarek J, Liguori C, Arthur A.

Support Care Cancer. 2019 May 23. doi: 10.1007/s00520-019-04850-w. [Epub ahead of print]

PMID:
31123871
2.

Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.

Del Bianco C, Placidi F, Liguori C, Mari L, Ulivi M, Ornello R, Pisani A, Mercuri NB, Izzi F.

Epilepsy Behav. 2019 May;94:178-182. doi: 10.1016/j.yebeh.2019.02.022. Epub 2019 Apr 6.

PMID:
30959275
3.

Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study.

Liguori C, Ruffini R, Olivola E, Chiaravalloti A, Izzi F, Stefani A, Pierantozzi M, Mercuri NB, Modugno N, Centonze D, Schillaci O, Placidi F.

Parkinsonism Relat Disord. 2019 Mar 23. pii: S1353-8020(19)30110-5. doi: 10.1016/j.parkreldis.2019.03.017. [Epub ahead of print]

PMID:
30930059
4.

Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.

Scaricamazza E, Colonna I, Sancesario GM, Assogna F, Orfei MD, Franchini F, Sancesario G, Mercuri NB, Liguori C.

Neurol Sci. 2019 Mar 22. doi: 10.1007/s10072-019-03840-4. [Epub ahead of print]

PMID:
30903419
5.

Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk?

Liguori C, Mercuri NB, Nuccetelli M, Izzi F, Cordella A, Bernardini S, Placidi F.

Sleep Med. 2019 Apr;56:171-176. doi: 10.1016/j.sleep.2019.01.003. Epub 2019 Jan 11.

PMID:
30799255
6.

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.

Liguori C, Turner K, Izzi F, Assogna M, Canevini MP, Mercuri NB, Placidi F.

CNS Neurosci Ther. 2019 May;25(5):632-637. doi: 10.1111/cns.13098. Epub 2019 Jan 23.

7.

CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD.

Liguori C, Paoletti FP, Placidi F, Ruffini R, Sancesario GM, Eusebi P, Mercuri NB, Parnetti L.

Curr Neurol Neurosci Rep. 2019 Jan 14;19(2):3. doi: 10.1007/s11910-019-0918-y. Review.

PMID:
30637520
8.

Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease.

Liguori C, Mercuri NB, Albanese M, Olivola E, Stefani A, Pierantozzi M.

J Neurol. 2019 Mar;266(3):636-641. doi: 10.1007/s00415-018-09179-8. Epub 2019 Jan 3.

PMID:
30607535
9.

New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay!

Liguori C, Moresco M, Izzi F, Mercuri NB, Plazzi G, Placidi F.

Psychiatry Clin Neurosci. 2019 Apr;73(4):194-195. doi: 10.1111/pcn.12816. Epub 2019 Feb 2. No abstract available.

PMID:
30588717
10.

Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study.

Alessandrini M, Liguori C, Viziano A, Izzi F, Capoccia D, Lanzillotta A, Placidi F, Mercuri NB, Micarelli A.

Sleep Breath. 2019 Jun;23(2):665-672. doi: 10.1007/s11325-018-1754-z. Epub 2018 Nov 19.

PMID:
30456739
11.

Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.

Romigi A, Franco V, Placidi F, Liguori C, Rastelli E, Vitrani G, Centonze D, Massa R.

Curr Neurol Neurosci Rep. 2018 Oct 31;18(12):102. doi: 10.1007/s11910-018-0903-x. Review.

PMID:
30382420
12.

Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms.

Liguori C, Mercuri NB, Nuccetelli M, Izzi F, Bernardini S, Placidi F.

J Alzheimers Dis. 2018;66(3):993-999. doi: 10.3233/JAD-180769.

PMID:
30372684
13.

Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study.

Rocchi C, Placidi F, Liguori C, Del Bianco C, Lauretti B, Diomedi M, Pisani A, Mercuri NB, Izzi F.

Sleep Med. 2018 Dec;52:163-167. doi: 10.1016/j.sleep.2018.08.023. Epub 2018 Sep 17.

PMID:
30359891
14.

Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis.

Liguori C, Ferini-Strambi L, Izzi F, Mari L, Manfredi N, D'Elia A, Mercuri NB, Placidi F.

Br J Clin Pharmacol. 2019 Jan;85(1):240-244. doi: 10.1111/bcp.13772. Epub 2018 Oct 24.

PMID:
30328132
15.

Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology.

Costa C, Romoli M, Liguori C, Farotti L, Eusebi P, Bedetti C, Siliquini S, Cesarini EN, Romigi A, Mercuri NB, Parnetti L, Calabresi P.

Neurobiol Aging. 2019 Jan;73:61-67. doi: 10.1016/j.neurobiolaging.2018.09.006. Epub 2018 Sep 18.

PMID:
30317034
16.

Does fatigue in Parkinson's disease correlate with autonomic nervous system dysfunction?

Olivola E, Brusa L, Rocchi C, Schillaci O, Liguori C, Cerroni R, Pierantozzi M, Chiaravalloti A, Stefani A, Stocchi F.

Neurol Sci. 2018 Dec;39(12):2169-2174. doi: 10.1007/s10072-018-3569-x. Epub 2018 Sep 25.

PMID:
30255487
17.

Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity.

Stefani A, Cerroni R, Mazzone P, Liguori C, Di Giovanni G, Pierantozzi M, Galati S.

Eur J Neurosci. 2019 Mar;49(6):805-816. doi: 10.1111/ejn.14088. Epub 2018 Aug 12. Review.

PMID:
30044030
18.

Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study.

Liguori C, Stefani A, Ruffini R, Mercuri NB, Pierantozzi M.

Parkinsonism Relat Disord. 2018 Dec;57:80-81. doi: 10.1016/j.parkreldis.2018.06.033. Epub 2018 Jun 30. No abstract available.

PMID:
30006034
19.

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine.

Liguori C, Izzi F, Manfredi N, Mercuri NB, Placidi F.

Epilepsy Behav Case Rep. 2018 Mar 12;10:35-37. doi: 10.1016/j.ebcr.2018.02.004. eCollection 2018.

20.

Continuous Positive Airway Pressure Treatment May Improve Optic Nerve Function in Obstructive Sleep Apnea: An Electrophysiological Study.

Liguori C, Placidi F, Palmieri MG, Izzi F, Ludovisi R, Mercuri NB, Pierantozzi M.

J Clin Sleep Med. 2018 Jun 15;14(6):953-958. doi: 10.5664/jcsm.7158.

21.

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression.

Liguori C, Pierantozzi M, Chiaravalloti A, Sancesario GM, Mercuri NB, Franchini F, Schillaci O, Sancesario G.

Front Aging Neurosci. 2018 Feb 23;10:38. doi: 10.3389/fnagi.2018.00038. eCollection 2018.

22.

Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea?

Izzi F, Placidi F, Liguori C, Lauretti B, Marfia GA, Pisani A, Mercuri NB, Rocchi C.

Sleep Med. 2018 Feb;42:68-72. doi: 10.1016/j.sleep.2017.09.029. Epub 2017 Oct 23.

PMID:
29458748
23.

Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.

Liguori C, Izzi F, Manfredi N, D'Elia A, Mari L, Mercuri NB, Fabio P.

Epilepsy Behav. 2018 Mar;80:173-176. doi: 10.1016/j.yebeh.2018.01.001. Epub 2018 Feb 3.

PMID:
29414548
24.

Is It Time to Consider Obstructive Sleep Apnea Syndrome a Risk Factor for Alzheimer's Disease?

Liguori C, Placidi F.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):855-856. doi: 10.1164/rccm.201710-2105ED. No abstract available.

PMID:
29373798
25.

Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients.

Liguori C, Mercuri NB, Stefani A, Pierantozzi M.

Sleep Med. 2018 Jan;41:113-114. doi: 10.1016/j.sleep.2017.09.017. No abstract available.

PMID:
29268951
26.

Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology.

Liguori C, Chiaravalloti A, Izzi F, Nuccetelli M, Bernardini S, Schillaci O, Mercuri NB, Placidi F.

Brain. 2017 Dec 1;140(12):e75. doi: 10.1093/brain/awx281. No abstract available.

PMID:
29077794
27.

Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment.

Liguori C, Romigi A, Izzi F, Placidi F, Nuccetelli M, Cordella A, Bernardini S, Biagio MN.

Epilepsy Res. 2017 Nov;137:107-111. doi: 10.1016/j.eplepsyres.2017.09.005. Epub 2017 Sep 21.

PMID:
28985614
28.

Letter re: Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia.

Liguori C, Izzi F, Mercuri NB, Placidi F.

Neurology. 2017 Oct 3;89(14):1532. doi: 10.1212/WNL.0000000000004551. No abstract available.

PMID:
28972108
29.

Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Liguori C, Chiaravalloti A, Nuccetelli M, Izzi F, Sancesario G, Cimini A, Bernardini S, Schillaci O, Mercuri NB, Fabio P.

J Neurol. 2017 Nov;264(11):2215-2223. doi: 10.1007/s00415-017-8613-x. Epub 2017 Sep 12.

PMID:
28900724
30.

Commentary: Sleep Changes without Medial Temporal Lobe or Brain Cortical Changes in Community-Dwelling Individuals with Subjective Cognitive Decline.

Liguori C, Izzi F, Mercuri NB, Placidi F.

Front Neurol. 2017 Jun 9;8:262. doi: 10.3389/fneur.2017.00262. eCollection 2017. No abstract available.

31.

Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments.

Liguori C, Piccirilli E, Izzi F, Mercuri NB, Tarantino U, Placidi F.

Eur Respir J. 2017 Apr 12;49(4). pii: 1602471. doi: 10.1183/13993003.02471-2016. Print 2017 Apr. No abstract available.

32.

Intermittent Short Sleep May Contribute to Orexinergic Signaling Dysregulation in Alzheimer's Disease.

Liguori C, Izzi F, Mercuri NB, Placidi F.

Sleep. 2017 Jan 1;40(1). doi: 10.1093/sleep/zsw027. No abstract available.

PMID:
28364471
33.

Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer's Disease Biomarkers Changes.

Liguori C, Mercuri NB, Izzi F, Romigi A, Cordella A, Sancesario G, Placidi F.

Sleep. 2017 May 1;40(5). doi: 10.1093/sleep/zsx011.

PMID:
28329084
34.

Integrating postural and vestibular dimensions to depict impairment in moderate-to-severe obstructive sleep apnea syndrome patients.

Micarelli A, Liguori C, Viziano A, Izzi F, Placidi F, Alessandrini M.

J Sleep Res. 2017 Aug;26(4):487-494. doi: 10.1111/jsr.12516. Epub 2017 Mar 20.

35.

Subthalamic nucleus deep brain stimulation on motor-symptoms of Parkinson's disease: Focus on neurochemistry.

Stefani A, Trendafilov V, Liguori C, Fedele E, Galati S.

Prog Neurobiol. 2017 Apr;151:157-174. doi: 10.1016/j.pneurobio.2017.01.003. Epub 2017 Jan 31. Review.

PMID:
28159574
36.

Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: further data.

Romigi A, Izzi F, Liguori C, Bove L, Pisani A, Placidi F, Mercuri NB.

Epilepsy Behav. 2017 Feb;67:137-138. doi: 10.1016/j.yebeh.2016.10.033. Epub 2017 Jan 19. No abstract available.

PMID:
28109779
37.

Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment.

Stefani A, Pierantozzi M, Olivola E, Galati S, Cerroni R, D'Angelo V, Hainsworth AH, Saviozzi V, Fedele E, Liguori C.

Neurochem Int. 2017 May;105:58-63. doi: 10.1016/j.neuint.2017.01.007. Epub 2017 Jan 18.

PMID:
28108196
38.

Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages.

Liguori C, Izzi F, Mercuri NB, Tarantino U, Placidi F.

Sleep Med. 2017 Apr;32:273. doi: 10.1016/j.sleep.2016.09.024. Epub 2016 Nov 17. No abstract available.

PMID:
28065400
39.

Impact of Diet and Nutrition on Cancer Hallmarks.

Chen KL, Jung P, Kulkoyluoglu-Cotul E, Liguori C, Lumibao J, Mazewski C, Ranard K, Rowles JL 3rd, Wang Y, Xue L, Madak-Erdogan Z.

J Cancer Prev Curr Res. 2017;7(4). pii: 240. doi: 10.15406/jcpcr.2017.07.00240. Epub 2017 Feb 17.

40.

Orexin and Alzheimer's Disease.

Liguori C.

Curr Top Behav Neurosci. 2017;33:305-322. doi: 10.1007/7854_2016_50. Review.

PMID:
28012089
41.

Vitamin D status of male OSAS patients improved after long-term CPAP treatment mainly in obese subjects.

Liguori C, Izzi F, Mercuri NB, Romigi A, Cordella A, Tarantino U, Placidi F.

Sleep Med. 2017 Jan;29:81-85. doi: 10.1016/j.sleep.2016.08.022. Epub 2016 Nov 3.

PMID:
27964863
42.

Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.

Liguori C, Olivola E, Pierantozzi M, Cerroni R, Galati S, Saviozzi V, Mercuri NB, Stefani A.

CNS Neurol Disord Drug Targets. 2017;16(3):339-345. doi: 10.2174/1871527316666161205123123.

PMID:
27934563
43.

Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?

Costa C, Parnetti L, D'Amelio M, Tozzi A, Tantucci M, Romigi A, Siliquini S, Cavallucci V, Di Filippo M, Mazzocchetti P, Liguori C, Nobili A, Eusebi P, Mercuri NB, Calabresi P.

Neurobiol Aging. 2016 Dec;48:161-171. doi: 10.1016/j.neurobiolaging.2016.08.025. Epub 2016 Sep 3.

PMID:
27701029
44.

Obstructive sleep apnoea and bone health.

Liguori C, Piccirilli E, Izzi F, Mercuri NB, Tarantino U, Placidi F.

Eur Respir J. 2016 Oct;48(4):1249-1250. doi: 10.1183/13993003.01219-2016. No abstract available.

45.

Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study.

Pierantozzi M, Placidi F, Liguori C, Albanese M, Imbriani P, Marciani MG, Mercuri NB, Stanzione P, Stefani A.

Sleep Med. 2016 May;21:140-4. doi: 10.1016/j.sleep.2016.01.016. Epub 2016 Feb 17.

PMID:
27448485
46.

Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.

Liguori C, Chiaravalloti A, Sancesario G, Stefani A, Sancesario GM, Mercuri NB, Schillaci O, Pierantozzi M.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2040-9. doi: 10.1007/s00259-016-3417-2. Epub 2016 May 25.

PMID:
27221635
47.

Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease.

Liguori C, Nuccetelli M, Izzi F, Sancesario G, Romigi A, Martorana A, Amoroso C, Bernardini S, Marciani MG, Mercuri NB, Placidi F.

Neurobiol Aging. 2016 Apr;40:120-126. doi: 10.1016/j.neurobiolaging.2016.01.007. Epub 2016 Jan 21.

PMID:
26973111
48.

Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases.

Liguori C, Romigi A, Placidi F, Sarpa MG, Mercuri NB, Izzi F.

Sleep Med. 2016 Jul;23:121-122. doi: 10.1016/j.sleep.2015.09.028. Epub 2015 Dec 2. No abstract available.

PMID:
26922622
49.

Role of Multidetector Computed Tomography in the Diagnosis of Colorectal Perforations.

Saturnino PP, Pinto A, Liguori C, Ponticiello G, Romano L.

Semin Ultrasound CT MR. 2016 Feb;37(1):49-53. doi: 10.1053/j.sult.2015.10.007. Epub 2015 Oct 17. Review.

PMID:
26827738
50.

Multidetector Computed Tomography of Pharyngo-Esophageal Perforations.

Liguori C, Gagliardi N, Saturnino PP, Pinto A, Romano L.

Semin Ultrasound CT MR. 2016 Feb;37(1):10-5. doi: 10.1053/j.sult.2015.10.005. Epub 2015 Oct 17. Review.

PMID:
26827733

Supplemental Content

Loading ...
Support Center